What is FDA product code QVF?

A simple point-of-care device to detect SARS-CoV-2 viral targets directly from clinical specimens in near-patient settings is an in vitro diagnostic device for the direct detection of SARS-CoV-2 in clinical specimens and is intended as an aid in the diagnosis of SARS-CoV-2 infections COVID-19). The device is simple to use and does not involve sample manipulation, transportation of the sample to another functional area (e.g., a central laboratory or other specialized area), or measurement of reagents or analytes that could be affected by conditions such as sample turbidity or cell lysis. The design and procedures of the device are appropriate for use by healthcare professionals in near-patient settings outside a centralized laboratory

BD Veritor System for Rapid Detection of SARS-CoV-2 · Simple Point-Of-Care Device to Directly Detect Sars-Cov-2 Viral Targets from Clinical Specimens in Near-Patient Settings → Immunology & Microbiology

Name: BD Veritor System for Rapid Detection of SARS-CoV-2
Brand: BD Veritor System for Rapid Detection of SARS-CoV-2

3manufacturers in China registered for this device type

1catalogue number

1510(k) clearance

Who Else Makes It

Concentrated in Zhejiang (1), Guangdong (1), elsewhere (1). One is registered as a contract manufacturer, able to build to a specification.

Chinese manufacturers registered for FDA product code QVF
Manufacturer	City	Province	Registered as	Device types
Zhejiang Orient Gene Biotech	Huzhou	Zhejiang	Contract manufacturer	86
Guangzhou Wondfo Biotech Co., Ltd.	Guangzhou	Guangdong	Contract manufacturer	44
BD Rapid Diagnostics (Suzhou) Co., Ltd.	China (Jiangsu) Pilot Free Trade Zone Suzhou Area		Manufacturer	6

Record

Regulatory record for BD Veritor System for Rapid Detection of SARS-CoV-2
Listed by	Becton, Dickinson AND Company, United States
FDA product code	QVF
Device type	Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings
Device class	Class 2
Regulation	21 CFR 866.3982
Establishment	Contract manufacturer, Contract steriliser, Specification developer, Repacker / relabeller, Manufacturer
510(k)	K243872
Record published	2025-08-21
Record revised	2026-04-17 (version 2)

Specifications

Specifications
MRI safety	Labeling does not contain MRI Safety Information
Single use	Yes
Prescription	Prescription only
Supplied as a kit	Yes
Label carries	lot or batch number, expiry date, manufacturing date
Storage	Storage environment temperature 2 to 30 °C; Special storage condition: Keep dry
Packaging	Pack or inner pack of 12

Catalogue Numbers

Catalogue numbers for BD Veritor System for Rapid Detection of SARS-CoV-2
Catalogue number	Size	Status
256092		In distribution

Same Product Code

Other products under the same FDA product code
Product	Sold by	Catalogue numbers
McKesson	Mckesson Medical-Surgical Inc.	2
SCoV-2 Ag Detect™ Rapid Test	Inbios International, Inc.	2
Sofia 2	Quidel Corp.	1
WELLlife™	Wondfo USA Co., Ltd.	1
Osom COVID-19 Test	Sekisui Diagnostics, LLC	1

510(K) Clearances

FDA 510(k) clearances naming this product code
Clearance	Decision date
K243872	2025-06-16

Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.

BD Veritor System for Rapid Detection of SARS-CoV-2